Chapters - Western Pacific

The Western Pacific Chapter was launched at the Annual ISoP Meeting in Bournemouth, UK in October 2007.
ISoP Chapters Western Pacific


At the Annual Meeting in Liege in October 2006, a group from New Zealand, Philippines and Australia discussed the possibility of establishing a regional Chapter of ISoP.

Chapters are locally established sub-groups of the Society which are intended to actively address the needs arising from a range of pharmacovigilance activities in their respective countries. One important aim is to enable ISoP members to be personally involved in the future of pharmacovigilance in their region.

Following on from these initial discussions, it was decided that the Chapter of ISoP should include members in the countries in the WHO Western Pacific region (as shown in Table 1).

Table 1: Countries included in the WHO Western Pacific Region

  • American Samoa
  • Australia*
  • Brunei Darussalam
  • Cambodia
  • China**
  • Cook Islands
  • Fiji
  • French Polynesia
  • Guam
  • Hong Kong (China)*
  • Japan*
  • Kiribati
  • Korea, Republic of*
  • Lao People’s Democratic Republic Tonga Macao (China)
  • Malaysia*
  • Marshall Islands
  • Micronesia, Federated States of
  • Nauru
  • New Caledonia
  • New Zealand*
  • Niue
  • Northern Mariana Islands
  • Palau
  • Papua New Guinea
  • Philippines*
  • Pitcairn Islands
  • Samoa
  • Singapore*
  • Solomon Islands
  • Tokelau
  • Tonga
  • Tuvalu
  • Vanuatu
  • Vietnam*
  • Wallis and Futuna

* Countries with current ISoP members
** The China chapter was officially launched in Agra, October 2016
** The Indonesia chapter was officially launched in Liverpool, October 2017

ISoP members in Indonesia**, Taiwan, and Thailand have also been included in the Western Pacific Chapter. There are currently no other ISoP members in countries in the South East Asia WHO region.

The first coordinator of the Western Pacific Chapter was Dr Mira Harrison-Woolrych who was the former Director of the New Zealand Intensive Medicines Monitoring Programme (IMMP). Dr Suzette Lazo – former President of the Philippine Society of Experimental and Clinical Pharmacology and a member of the ISoP committee on elections 2006 – had agreed to act as Secretary of the Chapter. Appointed in 2016, Dr Richard Hill from TGA is the new coordinator and is encouraging all those with a keen interest in pharmacovigilance in the Western Pacific region to consider joining ISoP and participate in activities in this region.

The Western Pacific Chapter was launched at the Annual ISoP Meeting in Bournemouth, UK in October 2007.

Anyone interested in joining the Western Pacific Chapter is invited to contact ISoP Administration.




ISoP Western Pacific Chapter

Mira Harrison-Woolrych, first coordinator of the Western Pacific Chapter, during the 7th ISoP Annual Meeting

Advisory Board

Appointed 2016

Dr Richard Hill
Therapeutic Goods Administration (TGA), Australia

Dr Ian Boyd
Former Board member of ISoP